Quick Order Cart

Cat. No. ARG34666

KRT5 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

A polyclonal population of HAP1 cells featuring CRISPR/Cas9-mediated disruption of the KRT5 gene, which encodes keratin 5??a type II intermediate filament protein that dimerizes with keratin 14 to form cytoskeletal networks. This model enables study of keratin-dependent structural integrity and signaling, involving regulators such as TP63 and Notch1, and downstream effectors including integrin ??6??4 and phospho-Akt. With a near-haploid genetic background derived from chronic myeloid leukemia, HAP1 cells simplify loss-of-function analysis. Applications include immunofluorescence, western blotting, adhesion, and scratch wound healing assays, supporting research in epidermolysis bullosa simplex and skin fragility.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KRT5

    Gene Identifier

    NCBI Gene ID 3852

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KRT5 Knockout HAP1 Polyclonal Cells product constitutes a heterogeneous polyclonal population of HAP1 cells in which CRISPR/Cas9-mediated gene disruption has been introduced at the KRT5 locus, encoding the type II intermediate filament protein keratin 5. This polyclonal knockout pool, without clonal selection, provides a robust loss-of-function model for interrogating keratin 5 biology across a diverse mutant allele background, ensuring representative phenotypes and minimizing clonal artifacts. The pool is specifically designed for applications requiring a mixed genotype, such as screening and population-level assays where clonal homogeneity is not prerequisite.

HAP1 is a near-haploid human cell line originally derived from the chronic myeloid leukemia line KBM-7. It exhibits a fibroblastoid morphology, male origin, and a stable near-haploid karyotype that reduces genetic redundancy and simplifies interpretation of loss-of-function phenotypes. Widely employed in haploid genetic screens and CRISPR-based knockout studies, HAP1 enables efficient gene disruption due to its single-copy genome. Although not of epithelial origin, HAP1 offers a clean background for ectopic expression or functional analysis of genes not endogenously expressed in hematopoietic cells, making it a versatile platform for biomedical research.

Keratin 5 is an obligate heterodimerization partner of keratin 14 (KRT14), with which it assembles into intermediate filament networks anchored at desmosomes and hemidesmosomes through interactions with desmoplakin, plectin, and BPAG1. This cytoskeletal scaffold links to laminin-332 in the basement membrane, maintaining epithelial mechanical integrity and facilitating mechanotransduction. Upstream, KRT5 expression is transcriptionally regulated by TP63 and Notch1, while downstream signaling involves integrin ??6??4?Cmediated activation of phospho-Akt. The network is further modulated by AP-1, EGF, and TGF-alpha, placing keratin 5 at a nexus of structural stability and signaling coordination in basal epithelial cells.

Disruption of KRT5 in HAP1 cells, despite their non-epithelial origin, serves as a model to dissect keratin filament assembly, stability, and interaction networks devoid of confounding endogenous keratin expression. In this background, ectopically expressed KRT5 and its partners can be studied to define structure?Cfunction relationships, while the polyclonal nature reflects a spectrum of mutation-induced phenotypes. This enables investigation of keratin-dependent processes such as cell adhesion, resistance to mechanical stress, and signaling downstream of integrin-mediated adhesion, which are fundamental to understanding diseases like epidermolysis bullosa simplex and squamous cell carcinoma.

Typical research applications include immunofluorescence microscopy to visualize intermediate filament organization, western blotting to assess KRT5 and KRT14 protein levels, cell adhesion and wound healing scratch assays to evaluate functional outcomes, co-immunoprecipitation for protein?Cprotein interactions, and phospho-signaling analyses to interrogate pathways downstream of keratin networks. The cells are suitable for modeling skin fragility syndromes, investigating keratin dynamics during epithelial-to-mesenchymal transition, and screening small molecules that modulate keratin cytoskeleton integrity. For additional information or customization, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)